查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829344

2025年全球鼻腔给药装置市场报告

Intranasal Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，鼻腔给药装置市场规模强劲成长，从2024年的602.7亿美元增加至2025年的650.9亿美元，复合年增长率为8.0%。预测期内的增长可归因于慢性呼吸系统疾病的增加、患者偏好和依从性、自我给药的便利性、儿科应用、过敏性鼻炎治疗市场的扩张以及适应症的广泛性。

预计未来几年，鼻腔给药装置市场规模将强劲成长，到2029年将达到910.5亿美元，复合年增长率为8.8%。预测期内的增长可归因于多种因素，例如老年人口的增长、全球呼吸系统疾病的日益严重、神经系统疾病应用的不断拓展、个性化医疗的趋势、预防医学的投入以及新兴国家的市场渗透。预测期内的主要趋势包括製剂技术的进步、对儿科和老年病应用的关注、自我给药装置和鼻腔粉吸入器的兴起，以及生技药品和多肽的加入。

鼻腔给药装置是用于将药物输送至鼻腔的医疗设备。这些装置专门设计用于将药物直接输送至血管丰富的鼻粘膜，鼻粘膜具有较大的表面积，可促进药物快速吸收进入血液。鼻腔给药装置可将各种形式的药物和治疗物质（包括喷雾剂、粉末和液体）直接输送至鼻腔。

鼻腔给药装置领域的主要产品包括粉末给药装置、液体给药装置、加压定量吸入器及其他相关装置。粉末给药装置是医疗器材或药物装置的一种，用于给药单位剂量或多剂量药物，适用于治疗各种疾病，包括慢性阻塞性肺病(COPD)、鼻炎、囊肿纤维化、鼻塞和气喘。这些装置的最终使用者包括医院、诊所、居家照护和其他医疗保健机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供鼻腔给药装置市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的鼻腔给药装置细分市场、市场趋势和商机，以及您在鼻腔给药装置行业取得成功所需的数据。本鼻腔给药装置市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.8%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。美国经济和贸易的负面影响，这种影响也可能影响更广泛的领域。

慢性病盛行率的上升预计将在未来几年推动鼻腔给药装置市场的成长。慢性病是指持续一年以上，需要持续医疗照护、限制日常活动或两者兼具的疾病。鼻腔给药装置是一种非侵入性且有效的给药方式，可用于治疗慢性病。此类装置可将药物直接输送至目标部位，方便易用且吸收迅速。例如，英国政府机构国家医疗服务体系（NHS）于2024年6月报告称，2023年，英格兰将有超过50万例（549,000例）新病例被确诊为有患2型糖尿病的风险。这将使在全科医生登记的非糖尿病高血糖或糖尿病前期患者总数达到3,615,330人，较2022年的3,065,825人大幅增加近20%。因此，慢性病盛行率的不断上升正在刺激鼻腔给药装置市场的扩张。

非侵入性给药方法日益增长的需求也有望促进鼻腔给药装置市场的扩张。非侵入性给药涉及将药物输送到体内，而无需穿透或切开皮肤或黏膜。鼻腔给药装置促进了这种方法，在使鼻腔给药变得简单有效方面发挥关键作用。这些装置利用鼻腔广泛的血管网络并确保快速吸收，从而提高药物生物生物有效性，提高患者依从性，并消除侵入性操作的需要。例如，美国美学协会于 2023 年 8 月发布的数据显示，美国非手术程序显着增加，预计到 2022 年，身体塑形、皮肤护理、毒素和微针疗法将分别增加 31%、26%、24% 和 23%。因此，对非侵入性给药方法日益增长的需求是推动鼻腔给药装置市场扩张的主要因素。

鼻腔给药技术市场领先的製药公司正在积极开发新产品和改进产品，以提供创新的给药方法并保持其市场地位。例如，2023年1月，美国药物输送和製药公司AptarGroup, Inc.推出了APF Futurity，这是首款可回收、无金属、多剂量鼻喷雾，用于输送鼻腔生理食盐水和类似的非处方(OTC)製剂。该产品由聚烯材料製成，不含金属成分和干扰回收的物质，减少了回收流程中的分离需求，并支援更高等级的回收材料。值得注意的是，APF Futurity是一款高度可回收的滴鼻剂泵，并已获得cyclos-HTP颁发的欧洲回收流程AA级认证。

2022年3月，诺华集团旗下瑞士生物製药公司山德士股份公司（Sandoz AG）收购了Coalesce Product Development Limited，收购金额未揭露。此策略措施旨在增强山德士在吸入式给药领域的能力，丰富其产品组合，并加速鼻腔给药装置的开发和商业化进程。 Coalesce Product Development Limited总部位于英国，专注于药物输送装置的开发，包括鼻腔给药。

鼻腔给药装置市场报告的主要企业包括强生公司、默克公司、诺华公司、阿斯特捷利康公司、葛兰素史克公司、3M 公司、贝克顿、迪金森公司、梯瓦製药工业有限公司、阿普塔集团公司、West Pharmaceutical Services 公司、泰利福公司、Recipharm AB、Nemera Development SA、Consort Ltd Services 公司、泰利福公司、Recipharm AB、Nemera Development SA、Consort Ltd Pvans、Virtical Pharmaceuticals、Optinoset Inc.、Flamel Technologies、 Aegis Therapeutics LLC、Sonoma Pharmaceuticals、Pendopharm Inc.、Kurbe Technology Inc.、Impel Neuropharma、Imexium Medical Products、BF Usher & Company Inc.、ENT Technologies Pty. Ltd.、Neurelis Inc.、Generex Biotechnology Corporation

2024 年，北美是鼻腔给药装置市场最大的地区。鼻腔给药装置市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

鼻腔给药装置市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。

鼻腔给药装置市场包括鼻喷雾、鼻粉剂装置、鼻用抗精神病药物、鼻用肾上腺素装置、滴鼻剂和鼻吸入器的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球鼻腔给药装置：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球鼻腔给药装置市场：成长率分析
  • 全球鼻腔给药装置市场表现：规模与成长，2019-2024
  • 全球鼻腔给药装置市场预测：规模与成长，2024-2029年，2034年
  • 全球鼻腔给药装置：总目标市场（TAM）

第六章 市场细分

  • 全球鼻腔给药装置市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 送粉装置
  • 液体输送装置
  • 加压定量吸入器
  • 其他产品
  • 全球鼻腔给药装置市场（依剂量、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 单位剂量
  • 多剂量
  • 全球鼻腔给药装置市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 慢性阻塞性肺病（COPD）
  • 鼻炎
  • 囊肿纤维化
  • 鼻塞
  • 气喘
  • 其他用途
  • 全球鼻腔给药装置市场：依最终用户、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家护理
  • 其他最终用户
  • 全球鼻腔给药装置市场：粉末输送装置（类型）细分、性能及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量粉末装置
  • 多剂量粉末装置
  • 全球鼻腔给药装置市场：液体输送装置（类型）细分、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量液体装置
  • 多剂量液体装置
  • 全球鼻腔给药装置市场：按压力定量吸入器 (pMDI) 细分，类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 呼吸激活PMDI
  • 常规pMDI
  • 全球鼻腔给药装置市场：依产品类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 凝胶输送装置
  • 喷雾器
  • 鼻喷剂

第七章 区域和国家分析

  • 全球鼻腔给药装置市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球鼻腔给药装置市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 鼻腔给药装置市场：竞争格局
  • 鼻腔给药装置市场：公司简介
    • Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • 3M Company
  • Becton, Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • AptarGroup Inc.
  • West Pharmaceutical Services Inc.
  • Teleflex Incorporated
  • Recipharm AB
  • Nemera Development SA
  • Consort Medical plc.
  • Vectura Group plc
  • Douglas Pharmaceuticals Ltd.
  • Avanir Pharmaceuticals
  • OptiNoset Inc.
  • Flamel Technologies
  • Aegis Therapeutics LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年鼻腔给药装置市场：提供新机会的国家
  • 2029年鼻腔给药装置市场：细分市场带来新机会
  • 2029年鼻腔给药装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r28357u

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $91.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for precision atomizing nozzles and biocompatible nasal adapters, sourced from key regions such as Germany and Switzerland, which could lead to reduced effectiveness of nasal vaccines and increased costs for alternative drug delivery methods.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of chronic diseases is anticipated to drive the growth of the intranasal drug delivery devices market in the coming years. Chronic diseases are defined as conditions lasting one year or more that require ongoing medical care, restrict daily activities, or both. Intranasal drug delivery devices are employed to manage chronic diseases by providing a non-invasive and effective means of administering medications. These devices enable medications to be delivered directly to the targeted area, offering convenience, ease of use, and promoting rapid absorption. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330, marking a significant increase from 3,065,825 in 2022 and representing nearly a 20% rise. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the intranasal drug delivery devices market.

The growing demand for non-invasive drug delivery methods is also expected to contribute to the expansion of the intranasal drug delivery device market. Non-invasive drug delivery involves administering pharmaceutical substances into the body without the need for skin or mucous membrane penetration or incision. Intranasal drug delivery devices play a crucial role in facilitating this approach, making it easy and effective to administer drugs through the nose. Leveraging the nose's extensive blood vessel network and ensuring fast absorption, these devices enhance drug bioavailability, improve patient adherence, and eliminate the need for invasive procedures. For example, data from The Aesthetic Society in August 2023 highlighted a significant increase in nonsurgical procedures in the U.S., with body contouring, skin treatment, toxins, and micro-needling showing growth rates of 31%, 26%, 24%, and 23%, respectively, in 2022. As a result, the growing demand for non-invasive drug delivery methods is a key driver for the expansion of the intranasal drug delivery device market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company under the Novartis Group, acquired Coalesce Product Development Limited for an undisclosed amount. This strategic move aims to enhance Sandoz's capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and expedite the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited, based in the UK, specializes in drug delivery device development, including nasal drug delivery.

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
  • 2) By Dosage: Unit-Dose; Multi-Dose
  • 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
  • 4) By End User: Hospitals; Clinics; Homecare; Other End Users
  • Subsegments:
  • 1) By Powder Delivery Device: Single-Dose Powder Device; Multi-Dose Powder Device
  • 2) By Liquid Delivery Device: Single-Dose Liquid Device; Multi-Dose Liquid Device
  • 3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs; Conventional pMDIs
  • 4) By Other Products: Gel Delivery Device; Nebulizers; Nasal Sprays
  • Companies Mentioned: Johnson and Johnson Inc.; Merck and Co.Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Becton, Dickinson and Company; Teva Pharmaceutical Industries Ltd.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Teleflex Incorporated; Recipharm AB; Nemera Development S.A.; Consort Medical plc.; Vectura Group plc; Douglas Pharmaceuticals Ltd.; Avanir Pharmaceuticals; OptiNoset Inc.; Flamel Technologies; Aegis Therapeutics LLC; Sonoma Pharmaceuticals; PendoPharm Inc.; Kurve Technology Inc.; Impel NeuroPharma; Impexium Medical Products; B.F. Ascher and Company Inc.; ENT Technologies Pty. Ltd.; Neurelis Inc.; Generex Biotechnology Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Drug Delivery Devices Market Characteristics

3. Intranasal Drug Delivery Devices Market Trends And Strategies

4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Intranasal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Intranasal Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM)

6. Intranasal Drug Delivery Devices Market Segmentation

  • 6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powder Delivery Device
  • Liquid Delivery Device
  • Pressurized Metered-Dose Inhalers
  • Other Products
  • 6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Unit-Dose
  • Multi-Dose
  • 6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Rhinitis
  • Cystic Fibrosis
  • Nasal Congestion
  • Asthma
  • Other Applications
  • 6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Other End Users
  • 6.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Powder Device
  • Multi-Dose Powder Device
  • 6.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Liquid Device
  • Multi-Dose Liquid Device
  • 6.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breath-Actuated PMDIs
  • Conventional pMDIs
  • 6.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gel Delivery Device
  • Nebulizers
  • Nasal Sprays

7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intranasal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intranasal Drug Delivery Devices Market

  • 9.1. China Intranasal Drug Delivery Devices Market Overview
  • 9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intranasal Drug Delivery Devices Market

  • 10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intranasal Drug Delivery Devices Market

  • 11.1. Japan Intranasal Drug Delivery Devices Market Overview
  • 11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intranasal Drug Delivery Devices Market

  • 12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intranasal Drug Delivery Devices Market

  • 13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intranasal Drug Delivery Devices Market

  • 14.1. South Korea Intranasal Drug Delivery Devices Market Overview
  • 14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intranasal Drug Delivery Devices Market

  • 15.1. Western Europe Intranasal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intranasal Drug Delivery Devices Market

  • 16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intranasal Drug Delivery Devices Market

  • 17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intranasal Drug Delivery Devices Market

  • 18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intranasal Drug Delivery Devices Market

  • 19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intranasal Drug Delivery Devices Market

  • 20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intranasal Drug Delivery Devices Market

  • 21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intranasal Drug Delivery Devices Market

  • 22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intranasal Drug Delivery Devices Market

  • 23.1. North America Intranasal Drug Delivery Devices Market Overview
  • 23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intranasal Drug Delivery Devices Market

  • 24.1. USA Intranasal Drug Delivery Devices Market Overview
  • 24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intranasal Drug Delivery Devices Market

  • 25.1. Canada Intranasal Drug Delivery Devices Market Overview
  • 25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intranasal Drug Delivery Devices Market

  • 26.1. South America Intranasal Drug Delivery Devices Market Overview
  • 26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intranasal Drug Delivery Devices Market

  • 27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intranasal Drug Delivery Devices Market

  • 28.1. Middle East Intranasal Drug Delivery Devices Market Overview
  • 28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intranasal Drug Delivery Devices Market

  • 29.1. Africa Intranasal Drug Delivery Devices Market Overview
  • 29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Intranasal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Intranasal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. 3M Company
  • 31.2. Becton, Dickinson and Company
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. AptarGroup Inc.
  • 31.5. West Pharmaceutical Services Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Recipharm AB
  • 31.8. Nemera Development S.A.
  • 31.9. Consort Medical plc.
  • 31.10. Vectura Group plc
  • 31.11. Douglas Pharmaceuticals Ltd.
  • 31.12. Avanir Pharmaceuticals
  • 31.13. OptiNoset Inc.
  • 31.14. Flamel Technologies
  • 31.15. Aegis Therapeutics LLC

32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

34. Recent Developments In The Intranasal Drug Delivery Devices Market

35. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Intranasal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Intranasal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Intranasal Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer